Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Mindfulness (N Y). 2018 Oct 9;10(5):775–785. doi: 10.1007/s12671-018-1032-y

Table 3.

Differential responsiveness of mindfulness and clinical outcomes, by condition

Meta-analysis Sensitivity analysis
Time Period Outcome Type Condition N k ES 95% CI I2 Q p kimp ESadj 95% CI

Pre-post Mindfulness Mindfulness 2083 50 -0.11 [−0.22,−0.01] 79.88 248.53 < .001 0
Mindfulness Waitlist 997 29 −0.18a [−0.25,−0.10] 39.98 45.62 .019 0
Mindfulness Bona fide 1439 29 −0.30a [−0.43,−0.16] 82.16 127.83 < .001 0
Pre-FU Mindfulness Mindfulness 764 16 -0.35 [−0.58, 0.11] 90.20 111.79 < .001 0
Mindfulness Waitlist 301 8 −0.32b [−0.65,0.01] 88.31 27.83 <.001 0
Mindfulness Bona fide 633 12 −0.47b [0.03, 0.27] 95.84 117.09 <.001 0

Note: ES = effect size (Δ ☐☐☐) quantifies degree to which responsiveness of mindfulness measures exceeds that for clinical outcome measures for the specified experimental condition (computed as gmindfulness-gclinical); FU = follow-up; CI = confidence interval; I2 =heterogeneity; Q = Q-statistic assessing degree of heterogeneity; p = p-value for Q-statistic; kimp = number of studies imputed using trim-and-fill analyses to account for funnel plot asymmetry; ESadj = trim-and-fill adjusted effect size;

a

= no significant difference between comparison group effect sizes (Q[1] = 1.57, p = .210);

b

= no significant difference between comparison group effect sizes (Q[1] = 0.22, p = .640). Type of mindfulness measure (FFMQ/KIMS, MAAS, or other) was tested as a moderator of differential responsiveness. There was no evidence for moderation by the measure of mindfulness used (ps > .050).